Cargando…
Scientific Opinion on development needs for the allergenicity and protein safety assessment of food and feed products derived from biotechnology
This Scientific Opinion addresses the formulation of specific development needs, including research requirements for allergenicity assessment and protein safety, in general, which is urgently needed in a world that demands more sustainable food systems. Current allergenicity risk assessment strategi...
Autores principales: | Mullins, Ewen, Bresson, Jean‐Louis, Dalmay, Tamas, Dewhurst, Ian Crawford, Epstein, Michelle M, George Firbank, Leslie, Guerche, Philippe, Hejatko, Jan, Naegeli, Hanspeter, Nogué, Fabien, Rostoks, Nils, Sánchez Serrano, Jose Juan, Savoini, Giovanni, Veromann, Eve, Veronesi, Fabio, Fernandez Dumont, Antonio, Moreno, Francisco Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787593/ https://www.ncbi.nlm.nih.gov/pubmed/35106091 http://dx.doi.org/10.2903/j.efsa.2022.7044 |
Ejemplares similares
-
Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
por: Naegeli, Hanspeter, et al.
Publicado: (2021) -
Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2010‐85) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87769 × MON 89788
por: Naegeli, Hanspeter, et al.
Publicado: (2021) -
Statement complementing the EFSA Scientific Opinion on the assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐BE‐2016‐138)
por: Mullins, Ewen, et al.
Publicado: (2022) -
Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis
por: Naegeli, Hanspeter, et al.
Publicado: (2020) -
Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐75) for placing on the market of genetically modified oilseed rape Ms8 × Rf3 × GT73 and subcombinations, which have not been authorised previously (i.e. Ms8 × GT73 and Rf3 × GT73) independently of their origin, for food and feed uses, import and processing, with the exception of isolated seed protein for food, under Regulation (EC) No 1829/2003), taking into consideration additional information
por: Naegeli, Hanspeter, et al.
Publicado: (2020)